Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.
Neuroblastoma is a malignant tumor that develops in infants and kids. Dysregulation of histone acetylation is associated with a series of malignant tumors. Neuroblastoma is caused by defective neural crest differentiation due to abnormal gene regulation.
Neuroblastoma in Children
DRUG: Tucidinostat and etoposide
Dose Limiting Toxicity (DLT), Dose-limiting toxicity defined as any Grade 4 hematological toxicity and any \> Grade 3 non-hematologic toxicity., 1 year|Maximum Tolerated Dose (MTD), Maximum tolerated dose is highest dose level in which 6 patients treated with at most 1 experiencing DLT., 1 year
Response Rate(ORR), Objective Response Rate（ORR）by RECIST 1.1,the total proportion of patients with complete response（CR）, partial response（PR）, 2 years|progression-free survival (PFS), Time from treatment until disease progression or death, 2 years|overall survival (OS), Time from treatment until death from any cause, 2 years|disease control rate (DCR), The total proportion of patients with complete response（CR）, partial response（PR）and Stable Disease（SD）, 2 years
Neuroblastoma is a malignant tumor that develops in infants and kids. Dysregulation of histone acetylation is associated with a series of malignant tumors. Neuroblastoma is caused by defective neural crest differentiation due to abnormal gene regulation.